CNTB stock

Connect Biopharma Holdings Ltd (CNTB) financials · rev $64.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Connect Biopharma Holdings Ltd (CNTB) rev $64.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$64.0K$26.0M
Operating Income-$58.1M-$22.5M
Net Income-$55.5M-$15.6M
EPS (Diluted)N/A-$0.28
Cached annual balance sheet
LineFY2025FY2024
Total Assets$56.1M$101.3M
Current Assets$50.9M$97.0M
Cash & Equivalents$38.3M$78.2M
PP&E$3.81M$4.05M
Total Liabilities$14.1M$9.12M
Current Liabilities$13.6M$8.46M
Shareholders' Equity$42.0M$92.2M
Retained Earnings-$400.8M-$345.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$51.2M-$23.6M
CapEx$434.0K$750.0K
Investing Cash Flow$9.82M-$3.45M
Financing Cash Flow$1.09M$227.0K
Net Change in Cash-$39.9M-$27.4M
Free Cash Flow-$51.6M-$24.4M
These statements as JSON? API free 100/day

FAQ

What is CNTB P/E and revenue?

Connect Biopharma Holdings Ltd (CNTB) rev $64.0K.

What is CNTB revenue?

Connect Biopharma Holdings Ltd last cached revenue is $64.0K (FY2025).

Is CNTB profitable?

Connect Biopharma Holdings Ltd last cached net income is -$55.5M (FY2025).

What are CNTB total assets?

Connect Biopharma Holdings Ltd last cached total assets are $56.1M (FY2025).

What is CNTB free cash flow?

Connect Biopharma Holdings Ltd last cached free cash flow is -$51.6M (FY2025).

Not investment advice. Cached statements, not a live tape.